Showing results (141-150 of 588) with videos related to

Sort By:
Pageof 59
American Journal of Epidemiology|August 31, 2013
Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancerJorge E Chavarro, Stacey A Kenfield, Meir J Stampfer, et al.
Molecular Cancer Therapeutics|March 12, 2009
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancerHan Xie, Vladimir A Valera, Maria J Merino, et al.
Nature Reviews. Disease Primers|March 10, 2017
Renal cell carcinomaJames J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
Cancer Research|June 18, 2002
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer familiesSiobhan S Wahlberg, James Schmeits, George Thomas, et al.
Molecular Cancer Research : MCR|August 27, 2003
Fatty acid synthase expression defines distinct molecular signatures in prostate cancerSabrina Rossi, Edgard Graner, Phillip Febbo, et al.
The Prostate|November 7, 2012
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survivalKathryn L Penney, Haojie Li, Lorelei A Mucci, et al.
Breast Cancer Research : BCR|August 3, 2017
AKT1<sup>low</sup> quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancerSheheryar Kabraji, Xavier Solé, Ying Huang, et al.
Breast Cancer Research and Treatment|February 27, 2003
Elevated serum periostin levels in patients with bone metastases from breast but not lung cancerHidefumi Sasaki, Chih-Yi Yu, Meiru Dai, et al.
BMC Cancer|December 21, 2014
Serum glucose and risk of cancer: a meta-analysisDanielle J Crawley, Lars Holmberg, Jennifer C Melvin, et al.
Circulation|August 25, 2010
Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathyJavid Moslehi, Yoji Andrew Minamishima, Jianru Shi, et al.
Pageof 59